Phase I Study of Milatuzumab for Graft Versus Host Disease
This study is not yet open for participant recruitment.
Verified March 2013 by Immunomedics, Inc.
Sponsor:
Immunomedics, Inc.
Collaborator:
Ohio State University
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT01663766
First received: August 7, 2012
Last updated: March 25, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |